| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,816 |
16,284 |
$1.14M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,435 |
13,183 |
$751K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
2,639 |
2,596 |
$247K |
| 99497 |
|
3,259 |
3,108 |
$126K |
| 99401 |
|
4,299 |
2,841 |
$111K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,225 |
1,198 |
$108K |
| 90746 |
|
1,080 |
1,072 |
$57K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,874 |
4,697 |
$55K |
| 93000 |
|
4,069 |
3,879 |
$40K |
| 90686 |
|
2,134 |
2,083 |
$33K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,068 |
950 |
$21K |
| 90674 |
|
910 |
883 |
$18K |
| 96127 |
|
3,775 |
3,632 |
$13K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
143 |
136 |
$13K |
| 99385 |
|
120 |
114 |
$11K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,731 |
1,526 |
$10K |
| 99402 |
|
188 |
187 |
$10K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
338 |
310 |
$9K |
| 90715 |
|
180 |
174 |
$7K |
| 99490 |
Ccm add 20min |
2,449 |
2,166 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
813 |
589 |
$6K |
| 99215 |
Prolong outpt/office vis |
104 |
94 |
$6K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
574 |
545 |
$4K |
| 90662 |
|
661 |
598 |
$4K |
| 94729 |
|
117 |
108 |
$4K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
1,098 |
950 |
$4K |
| 94726 |
|
117 |
109 |
$4K |
| 99223 |
Prolong inpt eval add15 m |
72 |
59 |
$3K |
| 90656 |
|
123 |
123 |
$3K |
| 94060 |
|
117 |
108 |
$3K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
119 |
98 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
398 |
249 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
38 |
38 |
$3K |
| 90739 |
|
17 |
15 |
$2K |
| 82962 |
|
2,596 |
2,221 |
$2K |
| S0257 |
Counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service) |
181 |
179 |
$2K |
| 99457 |
|
534 |
470 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
38 |
38 |
$2K |
| 99386 |
|
12 |
12 |
$2K |
| 90688 |
|
84 |
84 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
993 |
906 |
$1K |
| 99496 |
|
30 |
24 |
$1K |
| G0451 |
Development testing, with interpretation and report, per standardized instrument form |
429 |
370 |
$1K |
| 99458 |
|
461 |
397 |
$1K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
118 |
114 |
$1K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
79 |
26 |
$1K |
| 99454 |
|
230 |
193 |
$762.96 |
| 99483 |
Prolong outpt/office vis |
16 |
14 |
$747.12 |
| 99233 |
Prolong inpt eval add15 m |
20 |
13 |
$731.97 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
103 |
81 |
$705.61 |
| 94375 |
|
57 |
52 |
$532.84 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
207 |
189 |
$246.39 |
| 99439 |
|
82 |
76 |
$237.77 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12 |
12 |
$208.78 |
| 90694 |
|
34 |
29 |
$204.54 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
13 |
13 |
$95.65 |
| 99453 |
|
63 |
56 |
$91.98 |
| 99487 |
Ccm add 20min |
13 |
13 |
$41.85 |
| 1111F |
|
972 |
851 |
$36.00 |
| 82950 |
|
21 |
20 |
$14.06 |
| 3078F |
|
23,554 |
21,292 |
$2.00 |
| 1160F |
|
30,025 |
26,966 |
$2.00 |
| 3074F |
|
20,129 |
18,320 |
$1.00 |
| 3008F |
|
28,039 |
25,182 |
$1.00 |
| 1159F |
|
30,371 |
27,265 |
$1.00 |
| 1101F |
|
843 |
763 |
$0.00 |
| 1170F |
|
1,291 |
1,166 |
$0.00 |
| 3044F |
|
2,606 |
2,511 |
$0.00 |
| 3079F |
|
4,864 |
4,543 |
$0.00 |
| 3075F |
|
6,370 |
5,937 |
$0.00 |
| 1125F |
|
951 |
905 |
$0.00 |
| H0049 |
Alcohol and/or drug screening |
829 |
800 |
$0.00 |
| 3048F |
|
1,191 |
1,132 |
$0.00 |
| 1034F |
|
150 |
141 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
678 |
614 |
$0.00 |
| 2000F |
|
3,712 |
3,470 |
$0.00 |
| 1036F |
|
3,632 |
3,290 |
$0.00 |
| 1126F |
|
1,585 |
1,455 |
$0.00 |
| 3049F |
|
779 |
755 |
$0.00 |
| 2010F |
|
26,232 |
24,005 |
$0.00 |
| 3080F |
|
666 |
643 |
$0.00 |
| 4037F |
|
15 |
15 |
$0.00 |
| 0509F |
|
20 |
19 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
31 |
31 |
$0.00 |
| 36416 |
|
50 |
47 |
$0.00 |
| 0521F |
|
1,727 |
1,579 |
$0.00 |
| 2014F |
|
383 |
351 |
$0.00 |
| 3050F |
|
466 |
449 |
$0.00 |
| 1100F |
|
157 |
154 |
$0.00 |
| 3077F |
|
2,900 |
2,684 |
$0.00 |
| 3725F |
|
6,269 |
5,842 |
$0.00 |
| 1158F |
|
2,991 |
2,927 |
$0.00 |
| 0518F |
|
1,127 |
1,005 |
$0.00 |
| 1090F |
|
1,068 |
945 |
$0.00 |
| 99001 |
|
52 |
46 |
$0.00 |
| 3288F |
|
103 |
89 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
38 |
38 |
$0.00 |
| 1033F |
|
14 |
12 |
$0.00 |